AJM online
Clinical communication to the Editor
Vascular Endothelial Growth Factor in Systemic Capillary Leak Syndrome

https://doi.org/10.1016/j.amjmed.2009.01.020Get rights and content

References (10)

There are more references available in the full text version of this article.

Cited by (0)

Funding: The academic departments. Bevacizumab was provided without charge by Roche.

Conflict of Interest: Dr Punt declares that he has received fees as a member of the advisory board of Roche, manufacturer of bevacizumab. None of the other authors have any conflicts of interest associated with the work presented in this manuscript.

Authorship: All authors had access to the data and played a role in writing this manuscript.

View full text